- 4-Week # shares sold: 36,201
- 12-Week # shares sold: 46,201
- 24-Week # shares sold: 76,201
Jim Cramer likes International Paper and Inogen, but he's bearish on Teva Pharmaceuticals.
Jim Cramer says a well-diversified portfolio is a lot like a well-balanced and winning football team.
Goldman has a $64 price target on the company.